Overlaps withClinical Trial Supply China 2026
iPHEX is the pharma and healthcare export exhibition run by Pharmexcil (the Pharmaceuticals Export Promotion Council of India) under the Department of Commerce, held since 2013 and now in its 12th edition. The 2026 show fills Bharat Mandapam at Pragati Maidan with 700+ Indian exhibitors spanning formulations, APIs, biologics, vaccines, medical devices and packaging, and brings in 600+ hosted overseas buyers. It is structured around a reverse buyer-seller meet rather than a conference programme.
For cold chain professionals it is a sourcing floor: India supplies a large share of the world's generics and vaccines, and the importers, distributors and regulators who move that product are in the room negotiating supply. Temperature-controlled packaging, cold-storage and pharma-logistics vendors use it to reach exporters and overseas distributors. There is no dedicated cold-chain track, so the value is commercial contact and market access rather than technical content.
The delegate base is government-nominated hosted buyers, importers, distributors, wholesalers and agents of pharmaceuticals drawn from Africa, Latin America, the CIS, Southeast Asia and the Gulf, alongside Indian exporters and Pharmexcil member firms. Indian embassies and the Department of Commerce channel the overseas delegations. Attendees skew commercial and regulatory, export heads, procurement and regulatory-affairs staff, rather than logistics engineers.
Be the first to raise your hand.